Citation Impact
Citing Papers
Geography and macroeconomics: New data and new findings
2006 StandoutNobel
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes
2011
The EI Niño Southern Oscillation and the historic malaria epidemics on the Indian subcontinent and Sri Lanka: an early warning system for future epidemics?
1996
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Hepatocellular carcinoma
2003 Standout
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding
1998
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Acute kidney injury
2012 Standout
Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone
2005
Afferent mechanisms of sodium retention in cirrhosis and hepatorenal syndrome
2010
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
2007
Radiofrequency Ablation of Liver Cancer
2007
Liver fibrosis
2005 Standout
Hepatocellular carcinoma
2018 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective
2002
Factors Limiting Complete Tumor Ablation by Radiofrequency Ablation
2007
Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites
2016
Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials
2009
Climate change and malaria transmission
1996
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
2008
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment—Long-term Results
2016
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
2010
Initial Response To Percutaneous Ablation Predicts Survival in Patients With Hepatocellular Carcinoma
2004
Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm
2004
Hepatocellular Cancer: A Guide for the Internist
2007
Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer
2009
Intensive Care Unit Management of Patients with Liver Failure
2014
Use of thiopurines in inflammatory bowel disease: Safety issues
2014
Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism
2003
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis
2005
Image-guided ablation of primary liver and renal tumours
2015
TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: An updated meta-analysis
2014
Assessing ecosystem health
1998 Standout
Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis
1996
Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites
2004
The global distribution and burden of dengue
2013 StandoutNature
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
1998
The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation
2010
Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data
2007
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: Results in 85 patients
1996
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Acute kidney injury
2019 Standout
Training effects of short bouts of stair climbing on cardiorespiratory fitness, blood lipids, and homocysteine in sedentary young women
2005
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)
2008
The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club
2003
Treatment of Adamantiades-Behçet Disease With Systemic Interferon Alfa
1998
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency Ablation
2005
Improved clinical outcome using polytetrafluoroethylene-coated stents for tips: Results of a randomized study
2004
A CONTROLLED ANALYSIS OF THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN LIVER TRANSPLANT RECIPIENTS
1997
Yttrium-90 Microspheres: Radiation Therapy for Unresectable Liver Cancer
2002
Management of Cirrhosis and Ascites
2004
Model for end-stage liver disease (MELD) and allocation of donor livers
2003 Standout
Liver transplantation in patients with hepatic hydrothorax
2005
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
2020
A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites
2005
Role of antiviral treatment for HCC prevention
2014
Predicting key malaria transmission factors, biting and entomological inoculation rates, using modelled soil moisture in Kenya
1998
Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis
2015
Outcomes of patients with chest tube insertion for hepatic hydrothorax
2009
Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma
2016
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
Pulmonary complications in chronic liver disease
2013
The North American Study for the Treatment of Refractory Ascites
2003
Serial Pulse Oximetry in Hepatopulmonary Syndrome
2011
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Loco‐regional treatment of hepatocellular carcinoma†
2010
Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites
2012
The place of downstaging for hepatocellular carcinoma
2010
Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax
2011
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
Management of HCC
2012
Heat related mortality in warm and cold regions of Europe: observational study
2000
Ecological responses to recent climate change
2002 StandoutNature
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
Diagnosis and Treatment of Hepatocellular Carcinoma
2008
El Niño and health
2003
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis
2010
A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma
2005
Local-Regional Treatment of Hepatocellular Carcinoma
2011
Midterm Local Efficacy and Survival after Radiofrequency Ablation of Lung Tumors with Minimum Follow-up of 1 Year: Prospective Evaluation
2006
Regulatory T cells in tumor immunity
2010 StandoutNobel
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
2011
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies #
2008
Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: Comparison of patients with ascites, with refractory ascites, or without ascites
1998
Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series
2006
Serum bilirubin and platelet count: A simple predictive model for survival in patients with refractory ascites treated by TIPS
2010
Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts
2008
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial
1996
Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis
2015
Improved Quality of Life in Patients with Refractory or Recidivant Ascites after Insertion of Transjugular Intrahepatic Portosystemic Shunts
2002
Medical treatments for hepatocellular carcinoma (HCC): what’s next?
2006
Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
1998
Hepatocellular Carcinoma
2011 Standout
External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites1
2002
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial
2010
Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot study
2011
Behçet's Disease
1999 Standout
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis
2002
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of hepatocellular cancer
2005
Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
2002
The pros, cons, and many unknowns of probiotics
2019 Standout
Hepatocellular carcinoma
2022 Standout
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population
2008
Climate change and human health: present and future risks
2006 Standout
Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis
2016
Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study
2000
Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis
2017
Biological and Physical Signs of Climate Change: Focus on Mosquito-borne Diseases
1998
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression
2004
Impact of regional climate change on human health
2005 StandoutNature
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Complications After Percutaneous Saline-Enhanced Radiofrequency Ablation of Liver Tumors: 3-Year Experience with 336 Patients at a Single Center
2005
Global Change and Human Vulnerability to Vector-Borne Diseases
2004
Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis
2014
Estimates of the Damage Costs of Climate Change. Part 1: Benchmark Estimates
2002
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
2000 StandoutScience
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry
2010 StandoutNobel
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma
2013
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Early effects of climate change: do they include changes in vector-borne disease?
2000
Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis
2005
Climate Warming and Disease Risks for Terrestrial and Marine Biota
2002 StandoutScience
Globalization and the Sustainability of Human Health
1999
Early effects of climate change: do they include changes in vector-borne disease?
2001
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
2011
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial
2014
Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study
2018
Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials
2016
Management of people with early- or very early-stage hepatocellular carcinoma
2017
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Effectiveness of Phosphodiesterase‐5 Inhibitor Therapy for Portopulmonary Hypertension
2015
Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma
2005
Works of Peter Deibert being referenced
Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry
2006
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients
2001
Soy protein based supplementation supports metabolic effects of resistance training in previously untrained middle aged males
2011
The Transjugular Intrahepatic Portosystemic Stent–Shunt Procedure for Refractory Ascites
1995
Remission maintenance by tioguanine in chronic active Crohn's disease
2003
Effect of vardenafil, an inhibitor of phosphodiesterase‐5, on portal haemodynamics in normal and cirrhotic liver – results of a pilot study
2005
A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites
2000
6‐Thioguanine — efficacy and safety in chronic active Crohn's disease
2003
Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection—a single-center analysis including 132 patients
1998
Phosphodiesterase 5 inhibitors lower both portal and pulmonary pressure in portopulmonary hypertension: a case report
2007
Influence of Training Volume and Acute Physical Exercise on the Homocysteine Levels in Endurance-Trained Men: Interactions with Plasma Folate and Vitamin B<sub>12</sub>
2003
Small Hepatocellular Carcinoma in Cirrhosis: Randomized Comparison of Radio-frequency Thermal Ablation versus Percutaneous Ethanol Injection
2003
Loss of vision and diarrhoea
1997
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding
1997
Health and climate change
1994
The gastrointestinal system--an essential target organ of the athlete's health and physical performance.
1999